A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Pfizer Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 409,528 shares of PFE stock, worth $11.2 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
409,528
Previous 404,383 1.27%
Holding current value
$11.2 Million
Previous $11.2 Million 2.11%
% of portfolio
0.12%
Previous 0.12%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $129,962 - $152,292
5,145 Added 1.27%
409,528 $11.5 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.08 Million - $1.24 Million
-41,634 Reduced 9.33%
404,383 $11.2 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $788,707 - $1.02 Million
-30,184 Reduced 6.34%
446,017 $12.8 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $414,634 - $484,666
12,921 Added 2.79%
476,201 $15.8 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $729,804 - $844,366
-20,205 Reduced 4.18%
463,280 $17 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $3.53 Million - $4.6 Million
-89,667 Reduced 15.64%
483,485 $19.7 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $608,339 - $794,119
-14,571 Reduced 2.48%
573,152 $29.4 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $270,480 - $330,189
-6,181 Reduced 1.04%
587,723 $25.7 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $3.62 Million - $4.29 Million
77,845 Added 15.08%
593,904 $31.1 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $8.04 Million - $9.96 Million
-175,720 Reduced 25.4%
516,059 $26.7 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $28.6 Million - $42.4 Million
691,779 New
691,779 $40.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.